MEDICALMedication DosingHealth Calculator
🏥

Tramadol Dosage

45-year-old with moderate pain, starting IR tramadol

Did our AI summary help? Let us know.

Evidence-based calculations Used in clinical settings worldwide Regular monitoring recommended

Ready to run the numbers?

Why: This calculation helps assess important health parameters for clinical and personal wellness tracking.

How: Enter your values above and the calculator will apply validated formulas to compute your results.

Evidence-based calculationsUsed in clinical settings worldwide

Run the calculator when you are ready.

Understanding Tramadol DosageUse the calculator below to check your health metrics

💊 Adult - Moderate Pain

45-year-old with moderate pain, starting IR tramadol

Click to load

👵 Elderly Patient

78-year-old requiring reduced dosing

Click to load

🏥 Chronic Pain - ER

Patient converting to extended-release

Click to load

🩺 Renal Impairment

Patient with CKD requiring dose adjustment

Click to load

Clinical Scenarios

💊 Adult - Moderate Pain

45-year-old with moderate pain, starting IR tramadol

👵 Elderly Patient

78-year-old requiring reduced dosing

🏥 Chronic Pain - ER

Patient converting to extended-release

🩺 Renal Impairment

Patient with CKD requiring dose adjustment

Patient Information

For informational purposes only — not medical advice. Consult a healthcare professional before acting on results.

🏥 Health Facts

— WHO

— CDC

What is Tramadol?

Tramadol (Ultram, ConZip) is a centrally-acting synthetic opioid analgesic with a dual mechanism: weak mu-opioid receptor agonism and norepinephrine/serotonin reuptake inhibition. It's classified as a Schedule IV controlled substance and used for moderate to moderately severe pain in adults.

🧬

Dual Mechanism

Combines weak opioid effects with monoamine reuptake inhibition for synergistic analgesia.

Actions:

  • Mu-opioid receptor agonist
  • Serotonin reuptake inhibitor
  • Norepinephrine reuptake inhibitor
💊

Formulations

Available as immediate-release (IR) and extended-release (ER) formulations.

Options:

  • IR: 50 mg tablets
  • ER: 100, 200, 300 mg
  • Oral solution available
⚠️

Key Warnings

Unique risks including seizures and serotonin syndrome.

Risks:

  • Seizure risk (lower threshold)
  • Serotonin syndrome with SSRIs
  • Contraindicated in children <12

How This Calculator Works

🔬 Dosing Process

Calculation Steps

  1. 1Check for absolute contraindications
  2. 2Apply age-based dose adjustments
  3. 3Modify for renal/hepatic function
  4. 4Screen for drug interactions

Clinical Considerations

  • CYP2D6 polymorphisms affect metabolism
  • Active metabolite (M1) provides analgesia
  • Renal elimination - adjust in CKD
  • Seizure history increases risk

When to Use Tramadol

Tramadol occupies a unique position in pain management as a "step 2" analgesic on the WHO pain ladder. Its dual mechanism provides analgesia through both opioid and non-opioid pathways, making it useful for various pain types.

Moderate Pain

Acute or chronic moderate pain when NSAIDs are insufficient or contraindicated.

Indications:

  • Osteoarthritis pain
  • Low back pain
  • Post-operative pain
  • Fibromyalgia

Step 2 Analgesic

WHO pain ladder step 2 for cancer or non-cancer pain management.

Pain Ladder:

  • Step 1: Non-opioids (NSAIDs)
  • Step 2: Weak opioids (tramadol)
  • Step 3: Strong opioids

Lower Abuse Potential

When lower abuse potential is preferred vs traditional opioids (Schedule IV).

Advantages:

  • Schedule IV (vs II for most opioids)
  • Lower euphoria effect
  • Less respiratory depression

Contraindications and Precautions

Tramadol has specific contraindications that differ from other opioids due to its unique mechanism of action. Careful screening is essential before initiating therapy.

🚫

Absolute Contraindications

  • Age <12 years - FDA black box warning
  • MAOI use within 14 days
  • Severe hepatic impairment (Child-Pugh C)
  • Acute intoxication with alcohol, opioids, sedatives
  • Post-tonsillectomy in children 12-18 years
⚠️

Use with Caution

  • Seizure history - lowers seizure threshold
  • SSRIs/SNRIs - serotonin syndrome risk
  • CYP2D6 ultra-rapid metabolizers - increased M1 levels
  • Renal impairment (CrCl <30) - dose adjustment required
  • Obesity/OSA in adolescents 12-18 years

Dosing Guidelines by Population

Immediate Release (IR)

  • Starting: 25 mg every morning
  • Titration: Increase by 25 mg/day every 3 days
  • Target: 50-100 mg every 4-6 hours PRN
  • Maximum: 400 mg/day

Extended Release (ER)

  • Starting: 100 mg once daily
  • Titration: Increase by 100 mg every 5 days
  • Target: 100-300 mg once daily
  • Maximum: 300 mg/day
👴

Elderly (>75 years)

  • • Start 25 mg every 6 hours
  • • Max 300 mg/day
  • • Slower titration
  • • Monitor for CNS effects
🫘

Renal Impairment

  • • CrCl <30: Every 12 hours
  • • Max 200 mg/day
  • • Avoid ER in severe CKD
  • • Not dialyzable
🫀

Hepatic Impairment

  • • Child-Pugh B: Every 12 hours
  • • Max 100 mg/day
  • • Child-Pugh C: Avoid use
  • • Extended duration of action

Important Drug Interactions

Tramadol's dual mechanism creates unique interaction profiles not seen with other opioids. Both serotonergic and CYP450-mediated interactions must be considered.

🚨 Serotonin Syndrome Risk

Potentially life-threatening when combined with serotonergic drugs:

  • SSRIs - fluoxetine, sertraline, paroxetine
  • SNRIs - venlafaxine, duloxetine
  • TCAs - amitriptyline, nortriptyline
  • MAOIs - CONTRAINDICATED
  • Triptans - sumatriptan, rizatriptan
  • St. John's Wort

Symptoms to Watch:

Agitation, hyperthermia, tachycardia, tremor, hyperreflexia, incoordination

⚡ CYP450 Interactions

Tramadol is metabolized by CYP2D6 and CYP3A4:

  • CYP2D6 inhibitors (fluoxetine, paroxetine, bupropion) - reduce M1 formation, decrease efficacy
  • CYP3A4 inhibitors (ketoconazole, macrolides) - increase tramadol levels
  • CYP3A4 inducers (rifampin, carbamazepine) - decrease tramadol levels
  • Ultra-rapid CYP2D6 metabolizers - increased M1 levels, higher toxicity risk

Seizure Risk Management

Tramadol lowers the seizure threshold and can cause seizures even in patients without epilepsy. Risk is dose-dependent and increases with certain conditions and concurrent medications.

Risk Factors for Tramadol-Induced Seizures

Patient Factors

  • • History of seizures/epilepsy
  • • Head trauma
  • • CNS infections
  • • Metabolic abnormalities
  • • Alcohol withdrawal

Drug Factors

  • • High doses (>400 mg/day)
  • • Concurrent SSRIs/SNRIs
  • • Concurrent TCAs
  • • Concurrent antipsychotics
  • • Other drugs lowering threshold

Prevention Strategies

  • • Stay within recommended doses
  • • Avoid in high-risk patients
  • • Screen medication list
  • • Educate patients on symptoms
  • • Gradual dose escalation

Opioid Conversion Reference

Tramadol is considered a weak opioid with approximately 1/10th the potency of morphine. This conversion is important when transitioning patients to or from other opioids.

Equianalgesic Conversions

Tramadol DoseApproximate Morphine EquivalentNotes
50 mg5 mg oral morphineSingle dose
100 mg10 mg oral morphineStandard IR dose
200 mg/day20 mg/day morphine~20 MME
300 mg/day30 mg/day morphineER max dose
400 mg/day40 mg/day morphineIR max dose

Note: Conversion ratios are approximate. Individual response varies significantly due to CYP2D6 polymorphisms and other factors.

Common and Serious Adverse Effects

Tramadol's dual mechanism contributes to a unique adverse effect profile that includes both opioid-related and serotonergic side effects.

Common Side Effects (>10%)

  • Nausea/Vomiting - 24-40%, worse at initiation
  • Dizziness - 26-33%, often transient
  • Constipation - 24-46%, less than other opioids
  • Somnolence - 16-25%, caution with driving
  • Headache - 18-32%, often improves

Serious Adverse Events

  • Seizures - dose-dependent, avoid >400mg/day
  • Serotonin syndrome - especially with SSRIs
  • Respiratory depression - less than other opioids
  • Hypoglycemia - rare, monitor in diabetics
  • Adrenal insufficiency - with chronic use

Tapering and Discontinuation

Tramadol requires careful tapering due to its dual withdrawal syndrome - patients may experience both opioid withdrawal and SNRI-like discontinuation symptoms.

Recommended Taper Schedule

Gradual Reduction

  • 1Reduce by 10-25% every 1-2 weeks
  • 2Slower taper if symptoms emerge
  • 3May take 2-4 weeks total
  • 4Final steps may need smaller decrements

Withdrawal Symptoms

  • Opioid-type: muscle aches, diarrhea, restlessness
  • SNRI-type: anxiety, insomnia, paresthesias
  • Unique: hallucinations, severe anxiety, paranoia

Clinical Pearls

CYP2D6 Matters

Poor metabolizers get reduced analgesia; ultra-rapid metabolizers risk toxicity.

Slow Titration

Starting low and titrating slowly reduces GI side effects and improves tolerance.

Don't Crush ER

ER formulation must be swallowed whole. Crushing releases full dose immediately.

Naloxone Partial

Naloxone only partially reverses tramadol overdose - may need seizure management.

Withdrawal Risk

Abrupt discontinuation can cause both opioid and SNRI-type withdrawal.

Neuropathic Pain

Dual mechanism may provide benefit for neuropathic pain conditions.

Patient Counseling Points

Important Instructions

  • • Take exactly as prescribed - do not increase dose
  • • May be taken with or without food
  • • Swallow ER tablets whole - never crush or chew
  • • Avoid alcohol while taking tramadol
  • • Report any unusual symptoms (seizures, agitation, fever)

Safety Reminders

  • • May cause drowsiness - avoid driving until effects known
  • • Store securely away from children
  • • Do not share with others - it is a controlled substance
  • • Do not stop suddenly - taper under medical supervision
  • • Keep rescue medications (naloxone) if prescribed
👈 START HERE
⬅️Jump in and explore the concept!
AI

Related Calculators